PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer—an IMMUNOTARGET case series

BACKGROUND: Prior IMMUNOTARGET registry data had suggested that responses to immune [anti PD(L)1] monotherapy in gene-arranged non-small cell lung cancer (NSCLC) were rare or absent, depending on the specific oncogene. METHODS: IMMUNOTARGET sites reporting prior registry data or new individual cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Mushtaq, Rao, Cortot, Alexis B., Gautschi, Oliver, Mazieres, Julien, Camidge, D. Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830270/
https://www.ncbi.nlm.nih.gov/pubmed/36636412
http://dx.doi.org/10.21037/tlcr-22-329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830270/
https://www.ncbi.nlm.nih.gov/pubmed/36636412
http://dx.doi.org/10.21037/tlcr-22-329

Ejemplares similares